Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions
- PMID: 19299498
- DOI: 10.1164/rccm.200811-1729OC
Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions
Abstract
Rationale: Serum mesothelin is a new biomarker for the diagnosis of mesothelioma. Patients with mesothelioma commonly present with pleural effusions. To define the clinical utility of mesothelin quantification in pleural fluid, we assessed its additional value over pleural fluid cytology and its short-term reproducibility and reliability after pleural inflammatory processes, including pleurodesis.
Objectives: To assess the diagnostic role of pleural fluid mesothelin and the effect of common clinical factors that may influence measurement accuracy.
Methods: Mesothelin was quantified in 424 pleural fluid and 64 serum samples by ELISA. Fluid was collected prospectively from 167 patients who presented with pleural effusions for investigation. Serial pleural fluid samples were obtained from patients (n = 33) requiring repeated drainage. Mesothelin levels were also measured in patients (n = 32) prepleurodesis and postpleurodesis.
Measurements and main results: Pleural fluid mesothelin concentrations were significantly higher in patients with mesothelioma (n = 24) relative to those with metastatic carcinomas (n = 67) and benign effusions (n = 75): median (interquartile range, 25th-75th percentile) = 40.3 (18.3-68.1) versus 6.1 (1.5-13.2) versus 3.7 (0.0-12.4) nM, respectively, P < 0.0001. Mesothelin measurement was superior to cytological examination in the diagnosis and exclusion of mesothelioma (sensitivity, 71 vs. 35%; specificity, 89 vs. 100%; negative predictive value, 95 vs. 82%, respectively). In patients with "suspicious" cytology, pleural fluid mesothelin was 100% specific for mesothelioma, and in cytology-negative effusions (n = 105) offered a negative predictive value of 94%. Intraindividual reproducibility of pleural fluid mesothelin was excellent: mean (+/-SD) variation, -0.15 (+/-8.41) nM in samples collected within 7 days from patients with mesothelioma. Measurements remained reliable after pleurodesis and were not affected by the presence of bacteria.
Conclusions: Pleural fluid mesothelin provides additional diagnostic value relative to cytological examination. Mesothelin measurements are reproducible and not affected by inflammatory pleural processes.
Similar articles
-
Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma.Thorax. 2007 Jul;62(7):569-76. doi: 10.1136/thx.2006.068114. Epub 2007 Mar 13. Thorax. 2007. PMID: 17356060 Free PMC article.
-
Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesothelioma.Dis Markers. 2014;2014:413946. doi: 10.1155/2014/413946. Epub 2014 Nov 23. Dis Markers. 2014. PMID: 25505814 Free PMC article.
-
Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.Med Clin (Barc). 2009 Oct 3;133(12):449-53. doi: 10.1016/j.medcli.2008.11.047. Epub 2009 Sep 24. Med Clin (Barc). 2009. PMID: 19783262
-
[Contribution of pleural fluid analysis to the diagnosis of pleural effusion].Med Clin (Barc). 2015 Aug 21;145(4):171-7. doi: 10.1016/j.medcli.2014.08.005. Epub 2014 Nov 27. Med Clin (Barc). 2015. PMID: 25433793 Review. Spanish.
-
Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma: An updated meta-analysis.Medicine (Baltimore). 2019 Apr;98(14):e14979. doi: 10.1097/MD.0000000000014979. Medicine (Baltimore). 2019. PMID: 30946324 Free PMC article.
Cited by
-
Serum biomarkers in patients with mesothelioma and pleural plaques and healthy subjects exposed to naturally occurring asbestos.Lung. 2014 Feb;192(1):197-203. doi: 10.1007/s00408-013-9526-9. Epub 2013 Oct 30. Lung. 2014. PMID: 24170217
-
Developing a 'pleural team' to run a reactive pleural service.Clin Med (Lond). 2013 Oct;13(5):452-6. doi: 10.7861/clinmedicine.13-5-452. Clin Med (Lond). 2013. PMID: 24115700 Free PMC article.
-
Malignant pleural effusion: medical approaches for diagnosis and management.Tuberc Respir Dis (Seoul). 2014 May;76(5):211-7. doi: 10.4046/trd.2014.76.5.211. Epub 2014 May 29. Tuberc Respir Dis (Seoul). 2014. PMID: 24920947 Free PMC article. Review.
-
Assessment of potential predictors of calretinin and mesothelin to improve the diagnostic performance to detect malignant mesothelioma: results from a population-based cohort study.BMJ Open. 2017 Oct 11;7(10):e017104. doi: 10.1136/bmjopen-2017-017104. BMJ Open. 2017. PMID: 29025836 Free PMC article.
-
Loss of mesothelin expression by mesothelioma cells grown in vitro determines sensitivity to anti-mesothelin immunotoxin SS1P.Anticancer Res. 2012 Dec;32(12):5151-8. Anticancer Res. 2012. PMID: 23225411 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources